| Literature DB >> 32617833 |
Leticia Arrington1,2, Sebastian Ueckert1, Malidi Ahamadi2, Sreeraj Macha2, Mats O Karlsson3.
Abstract
This work evaluates the performance of longitudinal item response (IR) theory models in shortened assessments using an existing model for part II and III of the MDS-UPDRS score. Based on the item information content, the assessment was reduced by removal of items in multiple increments and the models' ability to recover the item characteristics of the remaining items at each level was evaluated. This evaluation was done for both simulated and real data. The metric of comparison in both cases was the item information function. For real data, the impact of shortening on the estimated disease progression and drug effect was also studied. In the simulated data setting, the item characteristics did not differ between the full and the shortened assessments down to the lowest level of information remaining; indicating a considerable independence between items. In contrast when reducing the assessment in a real data setting, a substantial change in item information was observed for some of the items. Disease progression and drug effect estimates also decreased in the reduced assessments. These changes indicate a shift in the measured construct of the shortened assessment and warrant caution when comparing results from a partial assessment with results from the full assessment.Entities:
Keywords: Composite score; Item information; Item response theory; Pharmacometrics
Year: 2020 PMID: 32617833 PMCID: PMC7520414 DOI: 10.1007/s10928-020-09697-x
Source DB: PubMed Journal: J Pharmacokinet Pharmacodyn ISSN: 1567-567X Impact factor: 2.745
Item level ranking of MDS-UPDRS components by information content and total cumulative % information content for items on motor subscale (34 Items)
| Cumulative % of total information remaining | ||||
|---|---|---|---|---|
| Item | Test name | Information at baseline for latent variable | Removal from most informative direction | Removal from least informative direction |
| 49 | Global Spont. of movement | 0.58 | 100 | |
| 35 | Finger Tap-left hand | 0.57 | ||
| 37 | Hand Move-left hand | 0.50 | 81 | |
| 18 | Dressing | 0.42 | 19 | |
| 39 | Pronation-supine-left hand | 0.42 | 71 | |
| 31 | Rigidity_LUE | 0.41 | 29 | |
| 28 | Facial expression | 0.37 | ||
| 29 | Rigidity_Neck | 0.33 | 59 | |
| 36 | Hand move-right hand | 0.32 | 41 | |
| 34 | Finger Tap-right hand | 0.32 | 51 | |
| 41 | Toe tap-left foot | 0.32 | 49 | |
| 24 | Getting out of bed | 0.30 | ||
| 33 | Rigidity_LLE | 0.29 | 41 | |
| 43 | Leg agility-Left leg | 0.29 | 59 | |
| 42 | Leg agility-Right leg | 0.27 | ||
| 40 | Toe tap-right foot | 0.24 | ||
| 48 | Posture | 0.21 | 29 | |
| 27 | Speech 3.1 | 0.21 | 71 | |
| 32 | Rigidity_RLE | 0.21 | ||
| 17 | Eating tasks | 0.20 | ||
| 25 | Walking and balancing | 0.20 | 20 | |
| 38 | Pronation-supine-right hand | 0.19 | 80 | |
| 30 | Rigidity_RUE | 0.19 | ||
| 21 | Doing hobbies and other activities | 0.19 | ||
| 22 | Turning in bed | 0.16 | ||
| 19 | Hygiene | 0.16 | 10 | |
| 14 | Speech | 0.15 | 90 | |
| 45 | Gait | 0.14 | ||
| 15 | Saliva and drooling | 0.14 | ||
| 44 | Arising from chair | 0.13 | ||
| 20 | Handwriting | 0.10 | ||
| 26 | Freezing | 0.09 | ||
| 16 | Chewing and swallowing | 0.08 | ||
| 47 | Postural stability | 0.04 | 100 | |
Items on row with percentage are also included in the information content decrement step
Fig. 1Item information curves for MDS-UPDRS motor items versus Disability for 100% scenario Vertical Lines indicate the disability range for 95% of the reference population
Fig. 2Efficiency on the population level for Real and Simulated data at each level of Reduced Information Content scenarios
Fig. 3Real world clinical data item level efficiency for MDS-UPDRS motor items versus disability (Removal of Least informative Items First). Vertical Lines indicate the disability range for 95% of the reference population
Fig. 4Real world clinical data item level efficiency for MDS-UPDRS motor items versus disability (Removal of Most informative Items First). Vertical Lines indicate the disability range for 95% of the reference population
Fig. 5Estimated population mean disease progression rate (latent variable/year) and Symptomatic drug effect estimates and 95% CI (shaded area) for observed motor subscale data at each level of reduced information content with least informative(left panel), Most Informative(right panel) removed first